The product line has optimally selected fluorochrome positions powered by AI analysis of the ideal excitation and emission profiles found in current commercially available fluorochromes. After conducting this analysis, BD designed dyes to fit these ideal profiles using cutting-edge dye technology.

Flow cytometry is a biomedical research technique with significant utility in biomarker discovery, drug development, and the expansion of immunological knowledge due to its potential for single-cell analysis, employing various dyes and reagents in the process.

The BD Horizon RealYellow and RealBlue Reagents optimize the capabilities of this technique for both conventional flow cytometry and spectral flow cytometry, while minimizing cross-laser excitation and background noise. These features promote more comprehensive cell analysis and expanded research insights.

BD Horizon RealYellow Reagents. Image courtesy of BD.

BD innovation highlights new flow cytometry tech
A new study conducted by Becton Dickinson (BD) in collaboration with the European Molecular Biology Laboratory, which was published as the cover story...

BD introduces robotics to automate microbial identification
BD has received clearance from the U.S. Food and Drug Administration for the BD Kiestra Identifa system, which is designed to automate the preparation...

BD launches new benchtop cell analyzer
Medical technology company Becton Dickinson (BD) has launched a new benchtop cell analyzer called FACSymphony A1 that offers new capabilities in flow...

BD launches new digital marketplace for flow cytometry
Becton Dickinson (BD) has launched bdbiosciences.com, an updated digital marketplace for flow cytometry. The new website provides an enhanced online purchasing...